AIHealthcare Analytics

Overview

Evernorth, Cigna's health services subsidiary, is investing $100 million through 2028 in a program called Pharmacy Forward, an AI-powered initiative aimed at improving specialty pharmacy operations and patient care outcomes.

Program Scope

Pharmacy Forward targets the specialty pharmacy sector — a high-cost, high-complexity segment of the pharmaceutical supply chain that handles medications for chronic and rare conditions. The $100M commitment signals Evernorth's belief that AI can meaningfully improve operational efficiency, medication adherence, and patient outcomes in this space.

Strategic Context

The investment reflects a broader industry trend of health services companies deploying AI to manage specialty drug costs, which are a primary driver of healthcare spending growth. Specialty pharmacy is a domain where AI-driven prior authorization, adherence monitoring, and care coordination can have outsized financial and clinical impact. Evernorth's commitment through 2028 suggests a multi-year technology buildout rather than a pilot program.